Comparing Bioprocess Architectures for Stem Cell Therapy Scale-Up

The journey from a promising stem cell line to a commercial therapy often stalls not on biology but on engineering: how do we grow enough cells, consistently, at a cost patients can afford? Bioprocess architecture—the combination of bioreactor design, feeding strategy, and harvest method—determines whether a therapy can reach thousands or remains a boutique treatment for a handful. Teams evaluating scale-up quickly encounter a bewildering menu of options: stirred-tank versus fixed-bed, batch versus perfusion, microcarriers versus suspension aggregates. Each choice carries consequences for yield, quality, and regulatory risk. This guide offers a structured comparison of the major architectures, grounded in the practical constraints of stem cell manufacturing. We focus on what matters most for process scientists and bioprocess engineers: how each system handles oxygen transfer, shear stress, nutrient gradients, and harvest logistics.